免責聲明: 本站彙整 FDA、ClinicalTrials.gov、PubMed、SEC EDGAR 等官方公開資料,僅供一般參考,不構成醫療建議、診斷、治療建議或投資建議。

FDA 510(k)

PERLA® TL後方骨板固定系統

K 號:K203506 · 2021-01-15

申請人Spineart
決定日期2021-01-15
產品代碼NKB
諮詢委員會或
決定相當於

器材摘要

PERLA® TL posterior osteosynthesis system is the device name listed in this FDA 510(k) record. The listed applicant is Spineart. It received FDA 510(k) clearance on 2021-01-15 under 510(k) number K203506. The device is classified under product code NKB. It was reviewed by the OR advisory panel. FDA Decision: Substantially Equivalent.

常見問題

What is the PERLA® TL posterior osteosynthesis system?

PERLA® TL posterior osteosynthesis system is a medical device that received FDA 510(k) clearance on 2021-01-15. The listed applicant is Spineart. The 510(k) number is K203506.

When did PERLA® TL posterior osteosynthesis system receive FDA 510(k) clearance?

PERLA® TL posterior osteosynthesis system received FDA 510(k) clearance on 2021-01-15, under 510(k) number K203506.

Who is the listed applicant for PERLA® TL posterior osteosynthesis system?

The FDA 510(k) record lists Spineart as the applicant. This does not by itself establish the device manufacturer.

What is the FDA product code for PERLA® TL posterior osteosynthesis system?

The FDA product code for PERLA® TL posterior osteosynthesis system is NKB.

相關臨床試驗

相關紀錄係使用名稱、產品代碼或其他後設資料自動配對。配對結果並不構成已驗證的臨床、科學、企業或監管關係,請查閱連結的官方來源。

其他以 Spineart 為申請人之記錄

相關紀錄係使用名稱、產品代碼或其他後設資料自動配對。配對結果並不構成已驗證的臨床、科學、企業或監管關係,請查閱連結的官方來源。

查看所有 23 項裝置 →

相關器械(代碼:NKB)

相關紀錄係使用名稱、產品代碼或其他後設資料自動配對。配對結果並不構成已驗證的臨床、科學、企業或監管關係,請查閱連結的官方來源。

官方來源

在 FDA 資料庫中查看 →

資料來源為 FDA Open API。如需最新且權威的資訊,請始終參閱官方記錄。

↑